home.aspx
 
. https://info.zs.com/activeingredient/clinical-development-risks-and-issues-in-a-covid-19-world
blog article
SHARESHARESHARE
CLINICAL DEVELOPMENT RISKS AND ISSUES IN A COVID-19 WORLD
Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2). JONATHAN ROWE READ MORE